JPWO2020160054A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020160054A5 JPWO2020160054A5 JP2021541715A JP2021541715A JPWO2020160054A5 JP WO2020160054 A5 JPWO2020160054 A5 JP WO2020160054A5 JP 2021541715 A JP2021541715 A JP 2021541715A JP 2021541715 A JP2021541715 A JP 2021541715A JP WO2020160054 A5 JPWO2020160054 A5 JP WO2020160054A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable form
- isotopic derivative
- structural formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000155 isotopic Effects 0.000 claims 24
- 150000001875 compounds Chemical class 0.000 claims 14
- 201000010099 disease Diseases 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 230000002730 additional Effects 0.000 claims 5
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 206010003816 Autoimmune disease Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010061598 Immunodeficiency Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 125000002015 acyclic group Chemical group 0.000 claims 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962799806P | 2019-02-01 | 2019-02-01 | |
| US62/799,806 | 2019-02-01 | ||
| PCT/US2020/015495 WO2020160054A1 (fr) | 2019-02-01 | 2020-01-28 | Dérivés d'imidazoquinoline amine, composition pharmaceutique, utilisation de ceux-ci |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022519474A JP2022519474A (ja) | 2022-03-24 |
| JPWO2020160054A5 true JPWO2020160054A5 (fr) | 2023-01-05 |
Family
ID=71840630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021541715A Pending JP2022519474A (ja) | 2019-02-01 | 2020-01-28 | イミダゾキノリンアミン誘導体、医薬組成物、その使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10954239B2 (fr) |
| EP (1) | EP3917926A4 (fr) |
| JP (1) | JP2022519474A (fr) |
| KR (1) | KR20210141461A (fr) |
| CN (2) | CN114585621B (fr) |
| AU (1) | AU2020216345A1 (fr) |
| CA (1) | CA3135161A1 (fr) |
| IL (1) | IL285277A (fr) |
| WO (1) | WO2020160054A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022008039A2 (pt) * | 2019-10-29 | 2022-07-12 | Prime Reach Trading Ltd | Compostos de 4-amino-imidazoquinolina e usos relacionados |
| EP4259198A1 (fr) * | 2020-12-09 | 2023-10-18 | University of Montana | Agoniste du récepteur de type toll |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1789042T3 (pl) * | 2004-09-02 | 2012-09-28 | 3M Innovative Properties Co | Układy pierścieni 1-alkoksy 1H-imidazo i sposoby |
| WO2007005644A2 (fr) | 2005-07-01 | 2007-01-11 | Concert Pharmaceuticals Inc. | Nouvelles aryloxypropanamines |
| US20070032555A1 (en) | 2005-07-01 | 2007-02-08 | Concert Pharmaceuticals Inc. | Novel aryloxyphenyl-propanamines |
| WO2007016361A2 (fr) | 2005-07-29 | 2007-02-08 | Concert Pharmaceuticals Inc. | Nouveaux composes pharmaceutiques |
| BRPI0615973A2 (pt) | 2005-07-29 | 2011-05-31 | Concert Pharmaceuticals Inc | novos derivados de benzo [d] [1,3] - dioxol |
| CN105294684B (zh) * | 2010-08-17 | 2018-04-06 | 3M创新有限公司 | 脂质化免疫反应调节剂化合物的组合物、制剂及方法 |
| EP3153180A1 (fr) * | 2011-06-03 | 2017-04-12 | 3M Innovative Properties Company | Lieurs hétérobifonctionnels avec segments de polyéthylène glycol et conjugués de modificateur de réponse immunitaire fabriqués à partir de ceux-ci |
| WO2014201245A1 (fr) * | 2013-06-12 | 2014-12-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Agoniste de tlr-9 comportant un agoniste de tlr-7 et/ou de tlr-8 pour traiter des tumeurs |
| KR101905292B1 (ko) * | 2014-04-22 | 2018-11-21 | 에프. 호프만-라 로슈 아게 | 4-아미노-이미다조퀴놀린 화합물 |
| WO2016183371A1 (fr) * | 2015-05-13 | 2016-11-17 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Procédés pour le traitement ou la prévention d'une lésion tissulaire ischémique |
| AR109629A1 (es) * | 2016-09-08 | 2019-01-09 | Medimmune Llc | Composiciones para la administración local de agonistas de receptores de tipo toll |
| CN111094285B (zh) * | 2017-09-05 | 2022-05-10 | 浙江海正药业股份有限公司 | 新型咪唑喹啉化合物及其制备方法和用途 |
-
2020
- 2020-01-28 AU AU2020216345A patent/AU2020216345A1/en active Pending
- 2020-01-28 EP EP20747804.1A patent/EP3917926A4/fr active Pending
- 2020-01-28 CA CA3135161A patent/CA3135161A1/fr active Pending
- 2020-01-28 WO PCT/US2020/015495 patent/WO2020160054A1/fr unknown
- 2020-01-28 CN CN202080025077.8A patent/CN114585621B/zh active Active
- 2020-01-28 CN CN202311404745.XA patent/CN117462549A/zh active Pending
- 2020-01-28 KR KR1020217027237A patent/KR20210141461A/ko not_active Application Discontinuation
- 2020-01-28 JP JP2021541715A patent/JP2022519474A/ja active Pending
- 2020-09-14 US US17/020,555 patent/US10954239B2/en active Active
-
2021
- 2021-02-17 US US17/177,333 patent/US20210163477A1/en active Pending
- 2021-08-01 IL IL285277A patent/IL285277A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6907173B2 (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| JP2020169171A5 (fr) | ||
| RU2018121314A (ru) | Применение производного рапамицина | |
| JPH0245486A (ja) | 治療用ヌクレオシド類 | |
| JP2018519302A5 (fr) | ||
| JPH08504176A (ja) | 製剤組成物 | |
| JP2003506348A (ja) | Ｃｃｒ−３受容体のインヒビターとしての尿素誘導体 | |
| JP2017524025A5 (fr) | ||
| RO119302B1 (ro) | Compoziţii farmaceutice cuprinzând sulfonamide ce conţin thf şi utilizarea acestora ca inhibitori ai aspartil proteazei | |
| JP2001507016A (ja) | サイクロスポリン誘導体、その製造及びそれを含有する製薬学的組成物 | |
| JPH0150700B2 (fr) | ||
| TWI794856B (zh) | 製備具有經取代之苯基或吡啶基部分的ｓｅｒｄ三環化合物的方法 | |
| JP2000505450A (ja) | キノロン類およびこれらの治療的使用 | |
| WO2016154524A1 (fr) | Inhibiteurs d'anhydrase carbonique et leurs utilisations | |
| DE4211812A1 (de) | Neue thalidomidderivate, ein verfahren zu deren herstellung sowie die verwendung derselben in arzneimitteln | |
| JPWO2020160054A5 (fr) | ||
| JP2691679B2 (ja) | オキシム誘導体およびそれを含有する医薬品 | |
| JP2002517443A (ja) | Ｈｉｖプロテアーゼ阻害剤の浸透を増加させる方法および組成物 | |
| JP2020111571A5 (fr) | ||
| SA98190179B1 (ar) | مركب carbocyclic nucleoside hemisulfate واستخدامه في معالجة الإصابات الفيروسية | |
| CN108698991B (zh) | 2-氧代吲哚化合物 | |
| JP2004536079A5 (fr) | ||
| EP0516725B1 (fr) | Nouvelle utilisation de linomide (r) | |
| WO2022033303A1 (fr) | Dérivé de benzylamine, son procédé de préparation et son utilisation | |
| RU2142798C1 (ru) | Средство на основе биологически активных уреидопроизводных для лечения инфекции, вызванной лентивирусом |